Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
28.09
-0.20 (-0.71%)
Feb 18, 2026, 2:57 PM EST - Market open
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $2.68 billion as of February 18, 2026. Its market cap has increased by 74.64% in one year.
Market Cap
2.68B
Enterprise Value
2.25B
1-Year Change
74.64%
Ranking
Category
Stock Price
$28.09
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $2.68B, an increase of 7,626.13%. That is a compound annual growth rate of 45.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 2.70B | -9.09% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 2.99B |
| Denali Therapeutics | 2.93B |
| Spyre Therapeutics | 2.84B |
| Beam Therapeutics | 2.76B |
| Apellis Pharmaceuticals | 2.75B |
| IDEAYA Biosciences | 2.65B |
| Tarsus Pharmaceuticals | 2.58B |
| Dyne Therapeutics | 2.56B |